Health Care & Life Sciences » Pharmaceuticals | Axim Biotechnologies Inc.

Axim Biotechnologies Inc.

Axim Biotechnologies Inc.
Stock Exchange Other OTC
EPS
$0.11
Market Cap
$50.49 M
Shares Outstanding
61.57 M
Public Float
12.42 M

Profile

Address
45 Rockefeller Plaza
New York New York 10111
United States
Employees -
Website http://www.aximbiotech.com
Updated 07/08/2019
AXIM Biotechnologies, Inc. engages in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand.

Financials

View All

George E. Anastassov
Chairman, President & Chief Executive Officer
Lekhram Changoer
Director & Chief Technology Officer